This website is intended for healthcare professionals

Cardiology

The earlier the better: statins to reduce cholesterol and cardiovascular disease

A recently published study evaluated incident cardiovascular disease (CVD) and the initiation as well as subsequent adherence to statin treatment for the treatment of primary prevention in those who...

Statin prescribing, preventative use and lipid levels

This review of the literature published in the Journal of Vascular Health and Risk Management (Reynolds et al, 2021), looked at the important area of the use of the drug group statins and the...

Evidence-based use of newer agents in type 2 diabetes

Recent accumulating evidence on the use of newer therapies in type 2 diabetes (T2DM) is helping to define their position in treatment. This information coupled with the increasing priority given...

Cardiovascular disease: the gender divide

According to statistics from the British Heart Foundation (BHF) there are 830 000 women in the UK living with coronary heart disease (CHD), and around 380 000 women in the UK have survived a heart...

Pharmacotherapy in arrhythmias: an overview of anti-arrhythmic drug therapy

Cardiac electrical impulses originate high in the hearts upper right chamber, the right atrium, at a highly dense area of electrical tissue called the sinoatrial (SA) node, located just below the...

Cardiac effects of cancer therapy and what is being done about it

The drug doxorubicin slows or stops the spread of cancer cells by blocking the enzyme, topoisomerase, which cancer cells rely on for their division and growth (Cancer Research UK (CRUK), 2019). It is...

The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors

The action of SGLT2 inhibitors is to reduce renal glucose and sodium reabsorption in the proximal tubule of the nephron resulting in increased urinary glucose excretion with osmotic and natriuretic...

Novel research into glucose-lowering drugs for heart failure shows promise

Alongside important lifestyle changes, first-line treatment for heart failure is an angiotensin-converting enzyme (ACE) inhibitor and a beta blocker licensed for heart failure in people with reduced...

Statins and the diet-heart hypothesis

‘Fake medical news and fearmongering… plague the cardiovascular world through relentless attacks on statins’ .

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP